OTC · Medical - Pharmaceuticals

BIMI International Medical Inc. (BIMI) Stock

$0.00 OTC: BIMI Healthcare

BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations. The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products.

Valuation

MetricValue
Price$0.00
Market Cap$1156
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-8.40
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-550.00%
ROA-61.11%
ROCE-148.16%
Gross Margin-125.00%
Operating Margin-125.00%
Net Margin-183.33%
Debt/Equity1.25
Current Ratio0.92

Annual Financials (USD)

Metric20182019202020212022
Revenue$7.0M$0$13.0M$21.0M$12.0M
Operating Profit$-16.0M$-1.0M$-4.0M$-8.0M$-15.0M
Net Profit$-17.0M$-4.0M$-5.0M$-35.0M$-22.0M
EPS$-112.25$-27.50$-24.80$-65.10$-8.40
Op Margin-241.4%-624.1%-29.7%-38.0%-129.7%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$23.0M$30.0M$33.0M$38.0M$36.0M
Total Liabilities$13.0M$22.0M$16.0M$27.0M$30.0M
Cash$0$0$0$5.0M$2.0M
Borrowings$6.0M$0$5.0M$9.0M$5.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$-2.0M$-4.0M$-1.0M$-10.0M
Investing Cash Flow$0$0$-1.0M$-2.0M$-1.0M
Financing Cash Flow$0$1.0M$0$0$4.0M
Net Cash Flow$0$0$0$5.0M$-2.0M
Free Cash Flow$0$-2.0M$-4.0M$-2.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.17
FCF Yield-887128.55%
Quick Ratio0.61
Interest Coverage-4.47
Return 1Y-99.00%
Return 3Y-100.00%
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BIMI International Medical Inc.

BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations. The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products. Its business activities are structured across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies. For its wholesale segment, BIMI distributes a wide range of specialized medical equipment, including Stryker spinal products, Olympus endoscopes, various imported imaging devices, and diagnostic imaging systems. These products are supplied to clients such as drugstores, private clinics, pharmaceutical dealers, and hospitals, particularly within China's Southwest region. The company also facilitates the distribution of a broad spectrum of pharmaceutical products, comprising generic medications, traditional Chinese herbal remedies, biochemical drugs, essential raw ingredients for pharmaceuticals, antibiotics, cardiovascular treatments, and anti-obesity medicines. Through its "Lijiantang Pharmacy" brand, BIMI operates a network of directly-owned retail outlets. These pharmacies offer consumers an extensive selection of items, including prescription and over-the-counter drugs, nutritional supplements, health foods, sundry goods, traditional Chinese medicines, personal and family care products, and medical devices. Beyond product sales, BIMI also delivers medical services within hospital environments and undertakes IT research and development initiatives.

BIMI International Medical Inc. (BIMI) stock trades at $0.00 with a market capitalization of $1156. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, BIMI International Medical Inc. generates a return on equity (ROE) of -550.00%, return on capital employed of -148.16%, an operating margin of -125.00%, a net profit margin of -183.33%.

Official website: www.usbimi.com/index.html

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides